Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells

JX Gao, H Zhang, XF Bai, J Wen, X Zheng… - The Journal of …, 2002 - rupress.org
JX Gao, H Zhang, XF Bai, J Wen, X Zheng, J Liu, P Zheng, Y Liu
The Journal of experimental medicine, 2002rupress.org
A number of in vitro studies have suggested that costimulatory molecules B7-1 and B7-2 and
their receptor CD28 can promote clonal deletion, and limited in vivo studies have indicated
that CD28 is involved in the clonal deletion of some T cells. However, the significance of B7-
mediated clonal deletion in preventing autoimmune diseases has not been studied
systematically. Here we report that the perinatal blockade of B7-1 and B7-2 substantially
inhibits the clonal deletion of T cells in the thymus and leads to an accumulation of T cells …
A number of in vitro studies have suggested that costimulatory molecules B7-1 and B7-2 and their receptor CD28 can promote clonal deletion, and limited in vivo studies have indicated that CD28 is involved in the clonal deletion of some T cells. However, the significance of B7-mediated clonal deletion in preventing autoimmune diseases has not been studied systematically. Here we report that the perinatal blockade of B7-1 and B7-2 substantially inhibits the clonal deletion of T cells in the thymus and leads to an accumulation of T cells capable of inducing fatal multiorgan inflammation. These results reveal a critical role for costimulatory molecules B7-1 and B7-2 in deleting pathogenic autoreactive T cells in the thymus. The critical role of B7-1 and B7-2 in T cell clonal deletion may explain, at least in part, the paradoxical increase of autoimmune disease in mice deficient for this family of costimulatory molecules, such as cytotoxic T lymphocyte associated molecule 4, CD28, and B7-2. The strong pathogenicity of the self-reactive T cells supports a central hypothesis in immunology, which is that clonal deletion plays an important role in preventing autoimmune diseases.
rupress.org